ASX Security code and description of the class of +securities the subject of the buy-back
PME : ORDINARY FULLY PAID
The type of buy-back is:
On market buy-back
Total number of +securities bought back before previous day
73,796
Total number of +securities bought back on previous day
5,800
Refer to next page for full details of the announcement
Notification of buy-back
1 / 6
Notification of buy-back
Part 1 - Entity and announcement details
For personal use only
1.1 Name of entity
PRO MEDICUS LIMITED
We (the entity named above) provide the following information about our buy-back.
1.2
Registration number type
Registration number
ABN
25006194752
1.3
ASX issuer code
PME
1.4 The announcement is
Update/amendment to previous announcement
1.4a Type of update
Daily buy-back notification
1.4b Reason for update
Daily buy-back notification
1.4c Date of initial notification of buy-back
1/4/2022
1.4d Date of previous announcement to this update
30/6/2022
1.5 Date of this announcement
4/7/2022
1.6 ASX Security code and description of the class of +securities the subject of the buy-back
PME : ORDINARY FULLY PAID
Notification of buy-back
2 / 6
Notification of buy-back
Part 2 - Type of buy-back
2.1 The type of buy-back is: On market buy-back
For personal use only
Notification of buy-back
3 / 6
Notification of buy-back
Part 3 - Buy-back details
only
Part 3A - Details of +securities, price and reason
3A.1 Total number of +securities on issue in the class of
+securities to be bought back
104,355,753
use
3A.4 Does the entity intend to buy back a minimum
number of +securities
No
3A.5 Does the entity intend to buy back a maximum
number of securities
Yes
3A.5a Maximum number of securities proposed to be
personal
bought back
10,435,575
3A.6 Name of broker or brokers who will offer to buy back +securities on the entity's behalf
Broker name:
Goldman Sachs
3A.9 Are the +securities being bought back for a cash consideration?
Yes
3A.9a Is the price to be paid for +securities bought back known?
No
3A.9a.1 In what currency will the buy-back consideration
be paid?
For
AUD - Australian Dollar
Part 3B - Buy-back restrictions and conditions
3B.1 Does the buy-back require security holder approval?
Notification of buy-back
4 / 6
Notification of buy-back
No
only
Part 3C - Key dates
On-marketbuy-back
3C.2 Proposed buy-back start date
use
1/4/2022
3C.3 Proposed buy-back end date
31/3/2023
personalFor
Part 3D - Other Information
3D.1 Any other information the entity wishes to notify to ASX about the buy-back
Notification of buy-back
5 / 6
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Pro Medicus Limited published this content on 03 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 July 2022 23:42:07 UTC.
Pro Medicus Limited is an Australia-based healthcare informatics company. It provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing two-Dimensional (2-D), 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers, training, installation and others.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
